FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of…

Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face

An operations manager finds relief from her depression with the help of psilocybin, the primary psychoactive component of “magic mushrooms.” A veteran conquers his post-traumatic stress disorder through therapy using…

MDMA Variants Show Promise for Safer Psychotherapy

Summary: Researchers developed three new MDMA variants (ODMA, TDMA, and SeDMA) that retain the therapeutic benefits while reducing side effects. These compounds affect mood-regulating brain structures similarly to MDMA but…

MDMA Makes People Feel More Connected During Conversations

Summary: Researchers shed light on MDMA’s potential to foster feelings of connection in controlled environments. Their study reveals that individuals on MDMA or methamphetamine felt more connected during conversations compared…

Psychedelics may better treat depression and anxiety symptoms than prescription antidepressants for patients with advanced cancer

In people with advanced cancer, psychedelic drugs like psilocybin, LSD and MDMA may significantly reduce the severity of depression and anxiety symptoms. Roughly 10% of patients with cancer experience anxiety,…